{"title":"Pilot Clinical Trial of NT-3 in CMT1A Patients","authors":"Z. Sahenk","doi":"10.1017/S1748232106000073","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":347111,"journal":{"name":"Progress in Neurotherapeutics and Neuropsychopharmacology","volume":"206 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2007-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neurotherapeutics and Neuropsychopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/S1748232106000073","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}